This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2001;286:2085.

	Since this article does not have an abstract, we have provided the first 126 words of the full text and any section headings.

The FDA is accepting applications for grant awards to support clinical trials of the safety and effectiveness of orphan products (drugs, biologics, medical devices, and medical foods) for treatment or diagnosis of diseases or conditions with fewer than 200 000 patients in the United States. The studies should provide the FDA with acceptable data that will substantially contribute to the approval of new products, or new indications for already marketed products. Due date for the receipt of grant applications is March 5, 2002.

For additional information, log onto http://www.fda.gov/orphan/grants or contact FDA Office of Orphan Products Development, 301-827-3666 or 1-800-300-7469; fax 301-827-0017. To subscribe to the FDA orphan products information service, log onto http://list.nih.gov/archives/orphanprodinfo.html.

Bernard A. Schwetz, DVM,PhD
Acting Principal Deputy Commissioner
Food and Drug Administration

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?